請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79068
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 葉秀慧 | zh_TW |
dc.contributor.advisor | Shiou-Hwei Yeh | en |
dc.contributor.author | 邱玉婷 | zh_TW |
dc.contributor.author | Yu-Ting Chiu | en |
dc.date.accessioned | 2021-07-11T15:41:21Z | - |
dc.date.available | 2024-02-28 | - |
dc.date.copyright | 2018-10-09 | - |
dc.date.issued | 2018 | - |
dc.date.submitted | 2002-01-01 | - |
dc.identifier.citation | 1. Paul S. Mater, S.P., Fields Virology, 6th Edition, 2013. 1: p. 825-858.
2. Perlman, S. and J. Netland, Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol, 2009. 7(6): p. 439-50. 3. Fehr, A.R. and S. Perlman, Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol, 2015. 1282: p. 1-23. 4. de Wit, E., et al., SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol, 2016. 14(8): p. 523-34. 5. Pasternak, A.O., W.J. Spaan, and E.J. Snijder, Nidovirus transcription: how to make sense...? J Gen Virol, 2006. 87(Pt 6): p. 1403-21. 6. Snijder, E.J., et al., Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. Journal of Molecular Biology, 2003. 331(5): p. 991-1004. 7. Kuhn, J.H., et al.,, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nat Rev Microbiol. 8. Dveksler, G.S., et al, Cloning of the mouse hepatitis virus (MHV) receptor: expression in human snd hamster cell linec confers susceptibility to MHV. J virol: p. 6881-91. 9. Burkard, C., et al., Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog, 2014. 10(11): p. e1004502. 10. Reid, C.R., A.M. Airo, and T.C. Hobman, The Virus-Host Interplay: Biogenesis of +RNA Replication Complexes. Viruses, 2015. 7(8): p. 4385-413. 11. Durai, P., et al., Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control. Exp Mol Med, 2015. 47: p. e181. 12. Blanchard, E. and P. Roingeard, Virus-induced double-membrane vesicles. Cell Microbiol, 2015. 17(1): p. 45-50. 13. Prentice, E., et al., Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem, 2004. 279(11): p. 10136-41. 14. Knoops, K., et al., SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol, 2008. 6(9): p. e226. 15. Wu, H.Y. and D.A. Brian, Subgenomic messenger RNA amplification in coronaviruses. Proc Natl Acad Sci U S A, 2010. 107(27): p. 12257-62. 16. Sawicki, S.G., D.L. Sawicki, and S.G. Siddell, A contemporary view of coronavirus transcription. J Virol, 2007. 81(1): p. 20-9. 17. Zuniga, S., et al., Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J Virol, 2010. 84(4): p. 2169-75. 18. Wu, C.H., et al., Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication. J Biol Chem, 2009. 284(8): p. 5229-39. 19. Wu, C.H., P.J. Chen, and S.H. Yeh, Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription. Cell Host Microbe, 2014. 16(4): p. 462-72. 20. Frieman, M., M. Heise, and R. Baric, SARS coronavirus and innate immunity. Virus Res, 2008. 133(1): p. 101-12. 21. Pillaiyar, T., Middle East Respiratory Syndrome-Coronavirus (MERS-CoV): An Updated Overview and Pharmacotherapeutics. Medicinal Chemistry, 2015. 22. Yang, Y., et al., The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell, 2013. 4(12): p. 951-61. 23. Frieman, M., et al., Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol, 2009. 83(13): p. 6689-705. 24. Huang, C., et al., SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathog, 2011. 7(12): p. e1002433. 25. Kopecky-Bromberg, S.A., et al., Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol, 2007. 81(2): p. 548-57. 26. Zhang, Z., et al., DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells. J Immunol, 2011. 187(9): p. 4501-8. 27. Zhang, Z., et al., DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity, 2011. 34(6): p. 866-78. 28. Oshiumi, H., et al., DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Eur J Immunol, 2010. 40(4): p. 940-8. 29. Miyashita, M., et al., DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Mol Cell Biol, 2011. 31(18): p. 3802-19. 30. Oshiumi, H., et al., DDX60 Is Involved in RIG-I-Dependent and Independent Antiviral Responses, and Its Function Is Attenuated by Virus-Induced EGFR Activation. Cell Rep, 2015. 11(8): p. 1193-207. 31. Valiente-Echeverria, F., M.A. Hermoso, and R. Soto-Rifo, RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity. Rev Med Virol, 2015. 25(5): p. 286-99. 32. Lu, X., et al., SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes, 2011. 42(1): p. 37-45. 33. Li, L., E.A. Monckton, and R. Godbout, A role for DEAD box 1 at DNA double-strand breaks. Mol Cell Biol, 2008. 28(20): p. 6413-25. 34. Goubau, D., S. Deddouche, and C. Reis e Sousa, Cytosolic sensing of viruses. Immunity, 2013. 38(5): p. 855-69. 35. Gack, M.U., Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens. J Virol, 2014. 88(10): p. 5213-6. 36. Melchjorsen, J., Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines. Viruses, 2013. 5(2): p. 470-527. 37. Zust, R., et al., Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol, 2011. 12(2): p. 137-43. 38. Chan, Y.K. and M.U. Gack, Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol, 2016. 14(6): p. 360-73. 39. Soulat, D., et al., The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J, 2008. 27(15): p. 2135-46. 40. Al-Tawfiq, J.A., et al., Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis, 2014. 20: p. 42-6. | - |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79068 | - |
dc.description.abstract | 無法有效誘導先天性免疫反應為冠狀病毒感染造成其嚴重致病的原因之一,多數冠狀病毒感染時會使干擾素生成受到抑制。許多病毒蛋白被認為參與在拮抗先天性免疫反應中,其中包括核殼蛋白,但詳細機制目前尚未明瞭。本研究的目的為探討冠狀病毒躲避干擾素生成的機制。利用老鼠冠狀病毒原型:鼠肝炎病毒 (mouse hepatitis virus, MHV) 的JHMV strain作為研究材料,我們發現當給予干擾素處理,病毒RNA生成和病毒力價 (viral titer)會因此降低;而如同預期,JHMV感染無法誘導干擾素生成與活化下游抗病毒之訊息傳遞路徑。在我們先前的研究中指出,DDX1與磷酸化核殼蛋白的交互作用參與調控JHMV的不連續轉錄機制進行,而DDX1為一RNA解旋酶,過去研究中曾報導其能夠作為sensor進而誘導干擾素產生,本研究因此提出探討在JHMV感染時,DDX1與磷酸化核殼蛋白的複合體參與調控先天興免疫反應的機制。
在穩定表現JHMV核殼蛋白的細胞中過量表現DDX1-Myc或是enzyme dead DDX1-Myc (K52A) 能夠誘導β型干擾素 (interferon beta, IFN-β) 產生,當給予GSK-3抑制劑抑制核殼蛋白磷酸化時,IFN-β生成則受到抑制,此結果顯示DDX1透過和磷酸化核殼蛋白的交互作用誘導的IFN-β生成,且與DDX1酵素活性無關。為了進一步了解其誘導機制,我們發現當knockdown RIG-I或是MAVS以及施予TBK1抑制劑時,能夠顯著減少IFN-β生成,此處理同時會造成DDX1表現量增加。根據此結果可推論DDX1與磷酸化核殼蛋白是透過活化RIG-I/MAVS/TBK1途徑進而誘導IFN-β生成,然而透過此途徑會進一步降低DDX1表現量造成IFN-β生成減少,可能為核殼蛋白參與拮抗先天性免疫反應之一可能機制。然而RIG-I/MAVS/TBK1途徑與DDX1/磷酸化核殼蛋白的新穎回饋循環 (feedback loop)調控機制仍有待進一步探討。 關鍵字:冠狀病毒、先天性免疫反應、DDX1、干擾素、核殼蛋白。 | zh_TW |
dc.description.abstract | One major pathogenic mechanism for severe coronavirus (CoV) infection is the failure to induce effective innate immune responses. The interferon (IFN) production is suppressed in most CoV infections. Several viral proteins have been identified involved in antagonizing the innate immune response, including the nucleocapsid (N) protein, but the mechanism still remained unclear. This study aims to study the mechanism for CoV to escape the IFN induction. Using the JHMV strain of mouse hepatitis virus (MHV), the prototype of CoV, we first found that the viral RNA production and viral titers were decreased upon IFNtreatment, and as expected, JHMV infection cannot induce IFN production and activate downstream antiviral signaling pathways. In our previous study, an interaction between DDX1 and phosphorylated N protein (pN) was identified involved in regulating the discontinuous transcription in JHMV. As DDX1, an RNA helicase, has been reported to function as a sensor to induce IFN responses, this study proposed to examine if DDX1 in complex with the pN protein is involved in regulating the IFN innate immune responses during JHMV infection.
Overexpression of either DDX1-Myc or the enzyme dead DDX1-Myc(K52A) in JHMV-N protein stably expressed DBT cells induced IFN-β production. Such an induction was abolished by treatment with the GSK-3 inhibitors, which significantly decreases the phosphorylation of N. The results suggested that DDX1 could via interacting with pN to induce IFN production, in an enzyme independent manner. To further dissect the mechanism, we found that knockdown of either RIG-I or MAVS expression and the treatment of TBK1 inhibitor significantly decreased the production of IFN-β, and interestingly the DDX1 was elevated at the same time. The results suggested that DDX1 and JHMV-pN induces IFN-β production through activation of the RIG-I/MAVS/TBK1 axis. This axis however in turn decreases the DDX1 level and thus leads to a decrease of IFN-β production. The detailed mechanism underlying this novel feed-back regulatory loop between RIG-I/MAVS/TBK1 axis and DDX1/CoV-pN awaits further investigation. Key words: coronavirus, innate immunity, DDX1, interferon, nucleocapsid. | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T15:41:21Z (GMT). No. of bitstreams: 1 ntu-107-R05445127-1.pdf: 4037635 bytes, checksum: 332d1729ffb0d63b203983865aacbbce (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 碩士論文口試委員審定書 I
誌謝 II 摘要 III Abstract IV 目錄 VI 圖表目錄 VIII 第一章、 序論 1 1.1 冠狀病毒的分類 1 1.2 冠狀病毒的傳播與致病性 1 1.3 冠狀病毒的基因結構 2 1.4 冠狀病毒的生活史 2 1.5 冠狀病毒的不連續轉錄現象 3 1.6 冠狀病毒和先天性免疫反應之相互關係 4 1.7 DExD-box helicase與先天性免疫反應之關係 5 實驗假說與目的 7 第二章、 材料與方法 8 2.1 質體轉形與製備 (Transformation and Plasmid extraction) 8 2.2 細胞培養 (Cell Culture) 8 2.3 病毒感染 (Virus Infection) 8 2.4 細胞轉染 (Transfection) 9 2.5 Lentivirus-shRNA gene knockdown 9 2.6 RNA萃取 (RNA extraction) 9 2.7 定量即時聚合酶連鎖反應 (Quantitative real-time Polymerase Chain Reaction, Q-PCR ) 9 2.8 北方墨點法 (Northern Blotting) 10 2.9 蛋白質萃取 (Protein extraction) 10 2.10 西方墨點法 (Western Blotting) 10 2.11 病毒斑分析 (Plaque Assay) 11 2.12 蔗糖濃度梯度沉降分析 (Sucrose Gradient Sedimentation Analysis) 11 第三章、 實驗結果 12 3.1 JHMV感染與先天性免疫反應之關係 12 3.2 DDX1解旋酶活性和核殼蛋白磷酸化程度與先天性免疫反應之相關性 12 3.3 DDX1和磷酸化核殼蛋白誘導先天性免疫反應之機制 14 3.4 造成DDX1和磷酸化核殼蛋白進行降解之機制 16 第四章、 討論 17 圖表 20 參考文獻 31 | - |
dc.language.iso | zh_TW | - |
dc.title | 冠狀病毒磷酸化核殼蛋白參與調控β型干擾素生成之角色研究 | zh_TW |
dc.title | Investigate the role of coronavirus phosphoylated nucleocapsid protein in regulating interferon-β production. | en |
dc.type | Thesis | - |
dc.date.schoolyear | 106-2 | - |
dc.description.degree | 碩士 | - |
dc.contributor.oralexamcommittee | 陳培哲;劉旻禕 | zh_TW |
dc.contributor.oralexamcommittee | Pei-Jer Chen;Min-Yi Liu | en |
dc.subject.keyword | 冠狀病毒,先天性免疫反應,DDX1,干擾素,核殼蛋白, | zh_TW |
dc.subject.keyword | coronavirus,innate immunity,DDX1,interferon,nucleocapsid, | en |
dc.relation.page | 33 | - |
dc.identifier.doi | 10.6342/NTU201803069 | - |
dc.rights.note | 未授權 | - |
dc.date.accepted | 2018-08-13 | - |
dc.contributor.author-college | 醫學院 | - |
dc.contributor.author-dept | 微生物學研究所 | - |
dc.date.embargo-lift | 2023-10-09 | - |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-2.pdf 目前未授權公開取用 | 3.94 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。